Percutaneous Cardiopulmonary Support Experience of a National University Hospital in Busan.
- Author:
Dong Hun SHIN
1
;
Min Jin LEE
;
Hae Jung NA
;
Sun Mi JANG
;
Jun Hyok OH
Author Information
- Publication Type:Original Article
- Keywords: Percutanous cardiopulmonary support
- MeSH: Busan; Cardiology; Heart Valve Diseases; Humans; Hyperbilirubinemia; Medical Records; Myocardial Infarction; Myocarditis; Respiratory Distress Syndrome, Adult; Retrospective Studies; Shock, Cardiogenic; Stroke; Weaning
- From:Kosin Medical Journal 2015;30(1):23-28
- CountryRepublic of Korea
- Language:Korean
- Abstract: OBJECTIVES: Cardiopulmonary support has been used to treat the patients with refractory cardiogenic shock since 1950s. In advent of portable system its use has been widened considerably. In this retrospective study, we report our single center experience concerning possible indications, complications and outcomes of percutanous cardiopulmonary support (PCPS). METHODS: From January 2013 to March 2014, we searched the patients who were supported by PCPS system by reviewing the medical records in cardiology department at our Hospital. Infectious organism was limited to what was identified within 2 weeks after weaning of PCPS. RESULTS: A total of 9 patients were supported by PCPS with CAPIOX CX(R) system (Terumo inc., Tokyo, Japan) initially for ST-segment elevation myocardial infarction/non ST-segment elevation myocardial infarction in 4 patients, myocarditis in 3 patients, valvular heart disease in 1 patient, and acute respiratory distress syndrome in 1 patient. The mean duration of PCPS support was 79.1+/-76.6 hours and 5 of them were recovered and discharged alive. All the patients needed transfusions of various forms of blood products. And there was one major stroke and one hyperbilirubinemia in related to PCPS treatment. CONCLUSIONS: PCPS treatment was a valuable means to treat the patients with cardiovascular collapse, but not without costs. Efforts to reduce its associated complications should be made to improve outcomes.
